Herbalife (HLF) reported a sales and EBITDA beat for Q4 vs. consensus estimates, with new distributor growth positive for the third consecutive quarter, DA Davidson tells investors in a research note. The firm, which made no change to its Neutral rating and $7.50 price target slightly raised its 2025E sales estimate to +0.8% year over year from +0.7% Y/Y, but lowering its EBITDA estimate by $15M to $631M. DA Davidson added that Herbalife’s only notable tariff risk is if Mexico were to impose retaliatory tariffs on goods imported to Mexico from the U.S.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.